Table 8.

Studies correlating neoangiogenesis and survival in NSCLC

First author	Year	Number of patients	Stage	Factor	Correlation
Giatromanolaki 6	1997	134	I, II	CD31	NS
Pastorino 8	1997	137	I	CD31	NS
Fontanini 9	1997	407	I–III	CD34	S
Duarte 26	1998	106	I	VIII, CD31	S, NS
Imoto 27	1998	91	I–III	VEGF	S
Matsuyama 11	1998	101	I–III	CD34	S
Decaussin 12	1999	81	I, II	VEGF	NS
Kakolyris 13	1999	69	I, II	CD31	S
Yano 5	2000	108	I–IV	CD34, VEGF	S, NS
Koukourakis 10	2001	102	I, II	VEGF	S
Han 14	2001	85	I	VEGF	S
Offersen 7	2001	143	I–III	VEGF, CD34	NS, NS
Tanaka 15	2001	236	I–III	CD105, CD34	S, NS

NS, not significant; NSCLC, non-small cell lung cancer; S, significant; VEGF, vascular endothelial growth factor.